Combined Effect of Dexamethasone and Paracetamol for Postoperative Sore Throat
Primary Purpose
Pharyngitis
Status
Unknown status
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Dexamethasone
Paracetamol
Sponsored by
About this trial
This is an interventional prevention trial for Pharyngitis focused on measuring Postoperative Period, Anesthesia, General, Intubation, Intratracheal, Dexamethasone, Acetaminophen
Eligibility Criteria
Inclusion Criteria:
- Patients scheduled for urologic surgery under general anesthesia
- ASA I-III
Exclusion Criteria:
- Patients with recent sore throat
- Patients with neck surgery
- Patients with anticipated difficult airway
- Patients with Mallampati grade 3
- Patients with severe cardiovascular or pulmonary disease
- Patients with allergic history to dexamethasone or paracetamol
- Patients with liver function disorder
- Patients with liver disease
Sites / Locations
- Seolu National University of Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Dexamethasone
Dexamethasone+ Paracetamol (DP)
Arm Description
Dexamethasone will be administered 30 minutes before the anesthetic induction.
Dexamethasone will be administered 30 minutes before the anesthetic induction. Paracetamol will be administered at the end of the surgery.
Outcomes
Primary Outcome Measures
Postoperative sore throat
Postoperative sore throat after 1 hour postoperatively will be measured (0:none, 1:mild, 2:moderate, 3:severe)
Secondary Outcome Measures
Postoperative sore throat degree
Postoperative sore throat degree after 0, 1, 6, 24 hour postoperatively will be measured (11 points, 0:none, 10:worst imaginable).
Postoperative pain
Postoperative pain after 0, 1, 6, 24 hour postoperatively will be measured (11 points, 0:none, 10:worst imaginable).
Nausea
Nausea will be measured at 0, 1, 6 and 24 hour postoperatively.
Vomiting
Vomiting will be measured at 0, 1, 6 and 24 hour postoperatively.
Somnolence
Somnolence will be measured at 0, 1, 6 and 24 hour postoperatively.
Shivering
Shivering will be measured at 0, 1, 6 and 24 hour postoperatively.
Headache
Headache will be measured at 0, 1, 6 and 24 hour postoperatively.
Hoarseness
Hoarseness will be measured at 0, 1, 6 and 24 hour postoperatively.
Dysphagia
Dysphagia will be measured at 0, 1, 6 and 24 hour postoperatively.
Analgesics
Analgesics usage will be measured at 0, 1, 6 and 24 hour postoperatively.
Postoperative sore throat
Postoperative sore throat after 0, 6, 24 hour postoperatively will be measured (0:none, 1:mild, 2:moderate, 3:severe)
Full Information
NCT ID
NCT02252419
First Posted
September 26, 2014
Last Updated
October 16, 2014
Sponsor
Seoul National University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT02252419
Brief Title
Combined Effect of Dexamethasone and Paracetamol for Postoperative Sore Throat
Official Title
Combined Effect of Preoperative Dexamethasone and Intraoperative Paracetamol on Postoperative Sore Throat for Patients Undergoing Urologic Surgery
Study Type
Interventional
2. Study Status
Record Verification Date
September 2014
Overall Recruitment Status
Unknown status
Study Start Date
October 2014 (undefined)
Primary Completion Date
February 2015 (Anticipated)
Study Completion Date
March 2015 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Seoul National University Hospital
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The investigators want to evaluate the efficacy of the dexamethasone and paracetamol for the prevention of postoperative sore throat.
Detailed Description
The postoperative sore throat is a common complication after the general anesthesia which decreases the quality of life. Dexamethasone is known to effective for the prevention of postoperative sore throat. The combined effect of the dexamethasone and paracetamol for postoperative sore throat, however, is not investigated.
The investigators want to evaluate the efficacy of the dexamethasone and paracetamol for the prevention of postoperative sore throat.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pharyngitis
Keywords
Postoperative Period, Anesthesia, General, Intubation, Intratracheal, Dexamethasone, Acetaminophen
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
242 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Dexamethasone
Arm Type
Active Comparator
Arm Description
Dexamethasone will be administered 30 minutes before the anesthetic induction.
Arm Title
Dexamethasone+ Paracetamol (DP)
Arm Type
Experimental
Arm Description
Dexamethasone will be administered 30 minutes before the anesthetic induction. Paracetamol will be administered at the end of the surgery.
Intervention Type
Drug
Intervention Name(s)
Dexamethasone
Intervention Description
Dexamethasone will be administered.
Intervention Type
Drug
Intervention Name(s)
Paracetamol
Intervention Description
Paracetamol will be administered.
Primary Outcome Measure Information:
Title
Postoperative sore throat
Description
Postoperative sore throat after 1 hour postoperatively will be measured (0:none, 1:mild, 2:moderate, 3:severe)
Time Frame
1 hour postoperatively
Secondary Outcome Measure Information:
Title
Postoperative sore throat degree
Description
Postoperative sore throat degree after 0, 1, 6, 24 hour postoperatively will be measured (11 points, 0:none, 10:worst imaginable).
Time Frame
0, 1, 6, 24 hour postoperatively
Title
Postoperative pain
Description
Postoperative pain after 0, 1, 6, 24 hour postoperatively will be measured (11 points, 0:none, 10:worst imaginable).
Time Frame
0, 1, 6, 24 hour postoperatively
Title
Nausea
Description
Nausea will be measured at 0, 1, 6 and 24 hour postoperatively.
Time Frame
0, 1, 6, 24 hour postoperatively
Title
Vomiting
Description
Vomiting will be measured at 0, 1, 6 and 24 hour postoperatively.
Time Frame
0, 1, 6, 24 hour postoperatively
Title
Somnolence
Description
Somnolence will be measured at 0, 1, 6 and 24 hour postoperatively.
Time Frame
0, 1, 6, 24 hour postoperatively
Title
Shivering
Description
Shivering will be measured at 0, 1, 6 and 24 hour postoperatively.
Time Frame
0, 1, 6, 24 hour postoperatively
Title
Headache
Description
Headache will be measured at 0, 1, 6 and 24 hour postoperatively.
Time Frame
0, 1, 6, 24 hour postoperatively
Title
Hoarseness
Description
Hoarseness will be measured at 0, 1, 6 and 24 hour postoperatively.
Time Frame
0, 1, 6, 24 hour postoperatively
Title
Dysphagia
Description
Dysphagia will be measured at 0, 1, 6 and 24 hour postoperatively.
Time Frame
0, 1, 6, 24 hour postoperatively
Title
Analgesics
Description
Analgesics usage will be measured at 0, 1, 6 and 24 hour postoperatively.
Time Frame
0, 1, 6, 24 hour postoperatively
Title
Postoperative sore throat
Description
Postoperative sore throat after 0, 6, 24 hour postoperatively will be measured (0:none, 1:mild, 2:moderate, 3:severe)
Time Frame
0, 6, 24 hour postoperatively
10. Eligibility
Sex
All
Minimum Age & Unit of Time
19 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients scheduled for urologic surgery under general anesthesia
ASA I-III
Exclusion Criteria:
Patients with recent sore throat
Patients with neck surgery
Patients with anticipated difficult airway
Patients with Mallampati grade 3
Patients with severe cardiovascular or pulmonary disease
Patients with allergic history to dexamethasone or paracetamol
Patients with liver function disorder
Patients with liver disease
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Hyun-Chang Kim, MD
Phone
82-10-2886-2876
Email
onidori1979@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hee-Pyoung Park, PhD
Organizational Affiliation
Seoul National University of Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Seolu National University of Hospital
City
Seoul
Country
Korea, Republic of
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hyun-Chang Kim, MD
Phone
83-10-2886-2876
Email
onidori1979@gmail.com
12. IPD Sharing Statement
Learn more about this trial
Combined Effect of Dexamethasone and Paracetamol for Postoperative Sore Throat
We'll reach out to this number within 24 hrs